Accordingly, pharmacological activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) was shown to prevent skeletal muscle pathology in different models of muscular atrophy [44,53,54]. The gene discussed is PRKAA1; the disease is muscular atrophy.